Details & Info
22nd Century Group, Inc. (NYSE:XXII) (FRA:22N) is a biotechnology company focusing on developing, marketing and licensing genetically-modified cannabis/ hemp/ marijuana plants as well as tobacco plants. Their cannabis focuses on producing hemp plants with low levels of THC for us as food, oil, fabric and more. Additionally, 22nd Century Group’s cannabis division works to produce marijuana plant varieties with high CBD levels for the medical cannabis industry. Their tobacco division focuses on producing tobacco plants with low levels of nicotine while maintaining flavor, smell and smokability.
Latest News & Filings
22nd Century Group, Inc. filed its Annual Report on Form 10-K for the year...Read more
22nd Century Group, Inc. announced that two studies published in Cancer Epidemiology, Biomarkers...Read more
22nd Century Group, Inc. met on Friday, February 14, 2020 with the U.S. Food and....Read more
Out of over 200+ marijuana stocks, here are 5 of the biggest marijuana stock losers today...Read more